Gastrointestinal stromal tumors (GIST) - A paradigm of successful targeted therapy of solid tumors;Gastrointestinalni stromalni tumori (GIST) - Paradigma uspješnog ciljanog lijecenja solidnih tumora

Acta Medica Croatica

Volumn 60, Issue 5, 2006, Pages 471-475

  Belev, Borislav ^a,b,c   Vrbanec, Damir ^a,c   Kralik, Marko ^b,c   Pleština, Stjepko ^a,c   Petričević, Branka ^a,c   Sirotković Skerlev, Maja ^a,c  

^a Klinika za Onkologiju   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

GIST; Imatinib; Solid tumors

Indexed keywords

IMATINIB; STEM CELL FACTOR;

ARTICLE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; QUALITY OF LIFE; SOLID TUMOR; TUMOR GROWTH; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 33845966780     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nishida T, Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 2000; 15: 1293-1301.
2. Pidhorecky I, Cheney RT, Kraybill WG i sur. Gastrointestinal stromal tumora: Current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000; 7: 705-12.
3. Miettinen M, Lasota J. Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438: 1-12.
4. Appelman HD. Mesenchymal tumors of the gut: Historical perspectives, new approaches, new results and does it make any difference? Monogr Pathol 1990; 21: 220-46.
5. Lee JR, Joshi V, Griffin JW i sur. Gastrointestinal autonomic nerve tumor: Immuno-histochemical and molecular idendity with gastrointestinal stromal tumor. Am J Surg Pathol 2001; 25: 979-87.
6. Rubin BP, Singer S, Tsao C i sur. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 2001; 61: 8118-21.
7. Lux M, Rubin BP, Biase TL i sur. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol 2000; 156: 791-5.
8. Joensuu H, Kindblom LG. Gastrointestinal stromal tumors: a review. Acta Orthop Scand Suppl 2004; 75: 62-71.
9. Fletcher CD, Berman JJ, Corless C i sur. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002; 33: 459-65.
10. Carney JA. The triad of gastric epitheloid leiomyosarcoma, functioning extraadrenal paraganglioma, and pulmonary chondroma. Cancer 1979; 43: 374-82.
11. Miettinen M, El-Rifai W, Sobin LH, Lasota J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 2002; 33: 478-83.
12. Kinblom LG, Remotti HE, Aldenborg F. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998; 152: 1259-69.
13. Sircar K, Hewlett BR, Huizinga JD i sur. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999; 25: 377-89.
14. Lauwers GY, Erlandson RA, Casper ES i sur. Gastrointestinal autonomic nerve tumors: A clinicopathologic, immunohistochemical and ultrastructural study of 12 cases. Am J Surg Pathol 1993; 17: 887-97.
15. Hirota S, Isozaki K, Moriyama Y i sur. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-80.
16. Nakahara M, Isozak K, Hirota S i sur. A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology 1998; 115: 1090-95.
17. Dematteo RP, Heinrich MC, El-Rifai W, Demetri G. Clinical management of gastro-intestinal stromal tumors: before and after STI-571. Hum Pathol 2002; 33: 466-77.
18. Pierie JP, Choudry U, Muzikansky A i sur. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001; 136: 383-9.
19. Knoop M, St Friedrichs K, Dierschke J. Surgical management of gastrointestinal stromal tumors of the stomach. Langebecks Arch Surg 2000; 385: 194-8.
20. Casper ES. Gastrointestinal stromal tumors. Curr Treat Options Oncol 2000; 1: 267-73.
21. Demetri GD. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. Semin Oncol 2001; 28: 19-26.
22. Berman J, O'Leavy TJ. Gastrointestinal stromal tumor workshop. Hum Pathol 2001; 32: 578-82.
23. Van Oosterom AT, Judson I, Verweij J i sur. Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumors. A phase I study. Lancet 2001; 358: 1421-23.
24. Joensuu H, Roberts PJ, Sarlomo-Rikala M i sur. Effect of the thyrosine kinase inhibitor ST1571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344: 1052-6.
25. Maki RG, Fletcher JA, Heinrich MC i sur. Results from a continuation trial of SU11248 in patients with imatinib-resistant gastrointestinal stromal tumors (GIST). Oral presentation no. 9011, ASCO Congress, 2005.